← BFNH
BFNH— BIOFORCE NANOSCIENCES HOLDINGS, INC.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Board of Directors Compensation | $423K+0.0% | $423K+0.0% | $423K+0.0% | $423K+0.0% | $423K-99.7% | $158.3M |
| General and Administrative | $67K-0.7% | $67K+37.8% | $49K-21.7% | $63K-20.8% | $79K-2.6% | $81K |
| Total Expenses | $490K-0.1% | $490K+3.9% | $472K-2.8% | $486K-3.3% | $502K-99.7% | $158.4M |
| Loss from Operations Before Loss on Liability Settlement | -$490K+0.1% | -$490K | — | — | — | — |
| Loss on Liability Settlement | -$802K | — | — | — | — | — |
| Net Loss | -$1.3M-163.4% | -$490K-3.9% | -$472K+2.8% | -$486K+3.3% | -$502K+99.7% | -$158.4M |
| Weighted Average Number of Common Shares - Basic | $33.2M+13.4% | $29.3M+0.0% | $29.3M+0.0% | $29.3M | — | — |
| Weighted Average Number of Common Shares - Diluted | $33.2M+13.4% | $29.3M+0.0% | $29.3M+0.0% | $29.3M | — | — |
| Net Loss for the Period Per Common Shares - Basic | -$0.04-100.0% | -$0.02+0.0% | -$0.02+0.0% | -$0.02 | — | — |
| Net Loss for the Period Per Common Shares - Diluted | -$0.04-100.0% | -$0.02+0.0% | -$0.02+0.0% | -$0.02 | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.